Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.08
-0.0500-4.42%
Post-market: 1.07-0.0100-0.93%18:39 EDT
Volume:41.11K
Turnover:46.13K
Market Cap:27.46M
PE:-2.75
High:1.19
Open:1.11
Low:1.07
Close:1.13
52wk High:5.48
52wk Low:0.6880
Shares:25.42M
Float Shares:20.60M
Volume Ratio:0.72
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3933
EPS(LYR):-0.3933
ROE:-119.49%
ROA:-31.25%
PB:2.47
PE(LYR):-2.75

Loading ...

Jul 29, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 21, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 08, 2021

Major Issues Report

8-K/A [Amend] - Current report
May 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K/A [Amend] - Current report
Apr 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Major Issues Report

8-K - Current report
Jan 08, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 22, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 15, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 15, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 24, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 17, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K - Current report